These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1658974)

  • 1. [Methadone maintenance of HIV-infected drug addicts with immune deficiency].
    Waal H; Knutsen T; Welle-Strand G
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3083-6. PubMed ID: 1658974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug use and HIV/AIDS in China.
    Liu Z; Lian Z; Zhao C
    Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experiences from two HIV prevention projects among drug abusers in Oslo. Is methadone maintenance treatment useful?].
    Skogstad M
    Tidsskr Nor Laegeforen; 1990 Jun; 110(15):1978-80. PubMed ID: 2363170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients.
    Novick DM; Joseph H; Croxson TS; Salsitz EA; Wang G; Richman BL; Poretsky L; Keefe JB; Whimbey E
    Arch Intern Med; 1990 Jan; 150(1):97-9. PubMed ID: 2297301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV prevention in HIV-positive drug addicts. A methadone-supported model].
    Oertle D; Edelmann R; Ostewalder J; Vernazza PL; Galeazzi RL
    Schweiz Med Wochenschr; 1993 Dec; 123(48):2284-92. PubMed ID: 8272803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV-infected drug addicts in a clinic for infectious diseases are dissatisfied and desire more treatment].
    Tokåker PO; Spångberg L; Pehrson P
    Lakartidningen; 1991 Mar; 88(12):1069, 1071-2. PubMed ID: 2016939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methadone dose, treatment duration and heroin use in drug-assisted rehabilitation].
    Kornør H; Waal H
    Tidsskr Nor Laegeforen; 2004 Feb; 124(3):332-4. PubMed ID: 14963504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Philadelphia's community based drug abuse program: broader medical and social concepts.
    Schut J
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):286-91. PubMed ID: 1167235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.
    Novick DM; Ochshorn M; Ghali V; Croxson TS; Mercer WD; Chiorazzi N; Kreek MJ
    J Pharmacol Exp Ther; 1989 Aug; 250(2):606-10. PubMed ID: 2788218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of treatment with methadone on utilization of medical care by addicts seropositive for the AIDS virus. Results of a descriptive study, Bayonne, 1996].
    Lafitte C; Bonnal F; Daulouede JP; Tignol J
    Encephale; 1998; 24(3):205-14. PubMed ID: 9696913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [General practitioners can take responsibility for medication-based rehabilitation].
    Skeie I; Brekke M; Lindbaek M; Waal H
    Tidsskr Nor Laegeforen; 2007 Feb; 127(3):296-7. PubMed ID: 17279108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heroin users seeking methadone treatment.
    Bell J; Fernandes D; Batey R
    Med J Aust; 1990 Apr; 152(7):361-4. PubMed ID: 2093804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts.
    Fernandez-Cruz E; Fernandez AM; Gutierrez C; Garcia-Montes M; de la Morena MT; Rodriguez-Villanueva J; Longo N; Zabay JM
    Clin Exp Immunol; 1988 May; 72(2):190-5. PubMed ID: 3261660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid scale up of harm reduction in China.
    Sullivan SG; Wu Z
    Int J Drug Policy; 2007 Mar; 18(2):118-28. PubMed ID: 17689354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers.
    De Castro S; Sabaté E
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S464-7. PubMed ID: 14648465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating the methadone patient in the traditional addiction inpatient rehabilitation program--problems and solutions.
    Kipnis SS; Herron A; Perez J; Joseph H
    Mt Sinai J Med; 2001 Jan; 68(1):28-32. PubMed ID: 11135503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.